Author:
,Brady Michael T.,Byington Carrie L.,Davies H. Dele,Edwards Kathryn M.,Glode Mary P.,Jackson Mary Anne,Keyserling Harry L.,Maldonado Yvonne A.,Murray Dennis L.,Orenstein Walter A.,Schutze Gordon E.,Willoughby Rodney E.,Zaoutis Theoklis E.
Abstract
On October 25, 2011, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommended that the quadrivalent human papillomavirus vaccine (Gardasil; Merck & Co, Inc, Whitehouse Station, NJ) be used routinely in males. The American Academy of Pediatrics has reviewed updated data provided by the Advisory Committee on Immunization Practices on vaccine efficacy, safety, and cost-effectiveness as well as programmatic considerations and supports this recommendation. This revised statement updates recommendations for human papillomavirus immunization of both males and females.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology, and Child Health
Reference6 articles.
1. Human papillomaviruses;American Academy of Pediatrics,2009
2. Prevention of human papillomavirus infection: provisional recommendations for immunization of girls and women with quadrivalent human papillomavirus vaccine [Retired];American Academy of Pediatrics Committee on Infectious Diseases;Pediatrics,2007
3. Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunization Practices (ACIP), 2011;Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2011
4. Condom use by adolescents;American Academy of Pediatrics, Committee on Adolescence;Pediatrics,2001
Cited by
75 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献